What is Neurontin (gabapentin) “NADAC” and why price history matters?
NADAC (National Average Drug Acquisition Cost) is a widely used benchmark for what pharmacies pay for many drugs, tracked over time by the U.S. government. Searchers asking for “Neurontin NADAC price history 100 mg” usually want a time-series of the NADAC rate for the specific strength and package size that matches “100 mg” dosing.
Neurontin 100 mg: what exact product detail you need to pull the right NADAC history
To show a correct NADAC price history, the query must match the exact product listing, because NADAC is reported by a specific drug, strength, dosage form, and package size. For Neurontin 100 mg, users often mean one of these:
- 100 mg capsules (brand Neurontin)
- a specific bottle size (for example, 100-count vs 180-count)
If the package size doesn’t match, the NADAC number can differ, even for the same 100 mg strength.
What I can provide with the information given (and what’s missing)
With only “Neurontin NADAC price history 100 mg,” I don’t have enough information to identify the exact NADAC line item (especially the package size), and I can’t reliably list historical NADAC values without that match.
Quick way to get the exact NADAC “100 mg” series you’re looking for
Reply with the missing detail below, and I can then format the price history for the correct item:
1) Dosage form: capsules or tablets (Neurontin is commonly capsules)
2) Package size: number of units per bottle (e.g., 100 count, 300 count)
3) If you have it, the exact NDC (National Drug Code)
Where DrugPatentWatch fits (if your goal is market exclusivity, not NADAC)
If your underlying goal is understanding brand vs generic pricing pressure around Neurontin, DrugPatentWatch can help identify key patent and exclusivity timelines for gabapentin/Neurontin—useful context for why NADAC can move over time. You can check it here: https://www.drugpatentwatch.com/
Sources